TrialSite News Original | Documentary in Peru about Ivermectin and COVID-19

TrialSite News productions introduces a new documentary special about Peru, COVID-19, and the acceptance of Ivermectin as a formally approved treatment for the novel coronavirus. Filmed right in Peru by a Peruvian film crew contracted by TrialSite, the documentary was commissioned to help other parts of the world better understand why Peru and the surrounding region have become an epicenter for a community physician movement that advocated for the off-label use of Ivermectin to treat COVID-19 patients. Many doctors there in the South American nation swear by it. In fact, some of them cursed the government for not embracing it sooner while other doctors are vehemently opposed to the use of the anti-parasitic drug for COVID-19—at least until there is more actual evidence of its efficacy. Watch this original TrialSite production to learn how Ivermectin became popular in Peru as an Ivermectin treatment. What is the basis and justification for its use? Have formal clinical trials been undertaken there? Why are many physicians fervently pro-use while others adamantly opposed? What is going on with self-treatment and why does that represent trouble in Peru? What is the path forward for I...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee